الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
31 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Amen Hamdy Zaki Ali 2023
32 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Amany Nasr Ahmed Mohammed Elemary 2023
33 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Prof. Ashraf Zeidan Abdalla Ahmed 2023
34 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Maged Abdelfatah Amine Hassan 2021
35 Bendamustine in Refractory / Relapsed Non Hodgkin Lymphoma Dr. Maged Abdelfatah Amine Hassan 2021
36 Relation of Estrogen Receptor Expression to Recurrence and Survival in Early and Locally Advanced Breast Cancer
 		Dr. Ahmed Mubarak Hefni Ismail 2021
37 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Dr. Hanaan Ahmed Mohammed Ahmed 2021
38 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Osama mostafa Abdelbadee Abou elhassan 2021
39 Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients Dr. Ahmed Refaat Abdel Zaher Mubarak 2021
40 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Ahmed Refaat Abdel Zaher Mubarak 2021